Among the subgroup of patients without HF, GLP-1 RA reduced the risk of hFH or CV death (HR 0.84, 95% CI 0.76 to 0.92) and ACM (HR 0.85, 95% CI 0.79 to 0.92). This evidence concerns the gene GLP1R and hydrops fetalis.